Individual differences and compliance intentions with COVID-19 restrictions: insights from a lockdown in Melbourne (Australia).


Journal

Health promotion international
ISSN: 1460-2245
Titre abrégé: Health Promot Int
Pays: England
ID NLM: 9008939

Informations de publication

Date de publication:
01 Jun 2022
Historique:
entrez: 28 7 2022
pubmed: 29 7 2022
medline: 2 8 2022
Statut: ppublish

Résumé

The coronavirus (COVID-19) pandemic has caused an international public health and economic crisis. Despite the COVID-19 vaccine rollout in many countries from late 2020, non-pharmaceutical interventions are still required to minimize the spread of the virus. However, notable variation in voluntary compliance with these interventions has been reported. This study investigated various individual differences associated with intentions to comply with COVID-19 restrictions during a sustained (112 day) lockdown in Melbourne (Australia) in late 2020. Participants (N = 363) completed an online survey where they responded to various socio-demographic, health and psychological questions. Participants also responded to a series of vignettes that assessed their intended behaviour in specific situations and their knowledge of the current COVID-19 restrictions. Overall, it was found that greater levels of organization predicted greater intentions to comply with the COVID-19 restrictions, while higher socio-economic status, sociability and anxiety predicted lower compliance intentions. Further, individuals previously diagnosed with COVID-19 reported lower intentions to comply with the COVID-19 restrictions. The strongest predictor of compliance intentions, however, was a greater knowledge of the current restrictions. These findings highlight that public health orders around COVID-19 restrictions should be presented in a clear and uncomplicated manner and should target specific groups to increase compliance.

Identifiants

pubmed: 35901172
pii: 6651170
doi: 10.1093/heapro/daac089
pmc: PMC9333189
pii:
doi:

Substances chimiques

COVID-19 Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press.

Références

BMJ. 2020 Dec 23;371:m4910
pubmed: 33361106
Appl Psychol Health Well Being. 2020 Dec;12(4):1224-1243
pubmed: 33052008
Soc Sci Med. 2021 Jan;268:113370
pubmed: 32980677
Public Health. 2020 May;182:163-169
pubmed: 32334182
Glob Transit. 2020;2:76-82
pubmed: 32835202
Science. 2020 May 22;368(6493):860-868
pubmed: 32291278
Prev Med. 2021 Dec;153:106713
pubmed: 34242662
Nat Commun. 2020 Nov 11;11(1):5710
pubmed: 33177507
BMC Public Health. 2021 Feb 13;21(1):352
pubmed: 33581734
Br J Health Psychol. 2010 Nov;15(Pt 4):797-824
pubmed: 20109274
Int J Public Health. 2020 Jul;65(6):731-739
pubmed: 32583009
Pers Individ Dif. 2021 Jun;175:110692
pubmed: 33526954
J Travel Med. 2020 Mar 13;27(2):
pubmed: 32052841
Emerg Infect Dis. 2020 May;26(5):976-984
pubmed: 32027585
Front Psychol. 2020 Oct 21;11:559288
pubmed: 33192820
Proc Natl Acad Sci U S A. 2021 May 25;118(21):
pubmed: 34011611
BMC Infect Dis. 2011 Jan 04;11:2
pubmed: 21199583
Sci Rep. 2021 Jan 21;11(1):1972
pubmed: 33479325
Science. 2021 Feb 26;371(6532):916-921
pubmed: 33479118
PLoS One. 2020 Oct 7;15(10):e0239795
pubmed: 33027281
Psychiatry Res. 2016 Jun 30;240:170-176
pubmed: 27107671
J Pers Assess. 2009 Jul;91(4):340-5
pubmed: 20017063
PLoS One. 2020 May 21;15(5):e0233668
pubmed: 32437434
Int J Biol Sci. 2020 Mar 15;16(10):1745-1752
pubmed: 32226294
BMJ. 2020 Jul 15;370:m2743
pubmed: 32669358
Soc Work Health Care. 2021;60(3):240-255
pubmed: 33407057
Public Adm Rev. 2020 Sep-Oct;80(5):805-814
pubmed: 32836442
Lancet Reg Health Eur. 2021 May;4:100061
pubmed: 33997831
Lancet. 2020 Jun 27;395(10242):1973-1987
pubmed: 32497510
Psychol Health Med. 2021 Jan;26(1):35-43
pubmed: 32490689

Auteurs

Jaime C Auton (JC)

School of Psychology, University of Adelaide, Australia.

Daniel Sturman (D)

School of Psychology, University of Adelaide, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH